Steroids can affect your eyes in several ways, with the two most common problems being elevated eye pressure that can lead to glaucoma and the formation of a specific type of cataract at the back of the lens. These risks apply whether you are taking steroid pills, using steroid eye drops, receiving steroid injections, or even using inhalers for asthma. The effects range from reversible pressure spikes that settle after stopping the drug to permanent vision loss from undetected nerve damage, and the outcome depends heavily on the type of steroid, how long you use it, and whether anyone is checking your eyes along the way.
The Two Big Risks at a Glance
Corticosteroids have been linked to ocular complications for decades. The main concerns are raised intraocular pressure (the pressure of the fluid inside your eye) and cataracts, but infections, delayed wound healing, and a retinal condition called central serous chorioretinopathy also show up in the medical literature.1Dermatologic Clinics. Ocular Effects of Topical and Systemic Steroids The timing differs by route: steroid eye drops tend to raise pressure within weeks, while oral steroids take months to do the same, and cataracts are far more commonly reported with oral or systemic therapy than with drops alone.2The Lancet. Ocular Effects of Topical and Systemic Corticosteroids
How Steroids Raise Eye Pressure
Your eye constantly produces a watery fluid that drains out through a sieve-like tissue called the trabecular meshwork. Steroids interfere with that drain. When researchers exposed trabecular meshwork cells to dexamethasone (a common corticosteroid), the tissue became roughly twice as stiff within three days, and the surrounding matrix became about four times stiffer with chronic exposure.3Investigative Ophthalmology & Visual Science. Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix That stiffening is accompanied by changes in structural proteins commonly implicated in glaucoma. Separately, steroids cause the internal scaffolding of these cells to reorganize into rigid lattice-like networks, which slows down cell movement and turnover, further clogging the drain.4Investigative Ophthalmology & Visual Science. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells
The result is that fluid builds up, pressure rises, and if nobody catches it, the optic nerve takes damage. This is steroid-induced glaucoma. Multiple molecular pathways are involved, including changes in collagen production, inflammation signaling, and cell aging, all of which have been confirmed when comparing steroid “responders” (people whose pressure goes up) with non-responders.5Investigative Ophthalmology & Visual Science. The Molecular Processes in the Trabecular Meshwork After Exposure to Corticosteroids and in Corticosteroid-Induced Ocular Hypertension
Who Is Most Likely to Get a Pressure Spike
Not everyone who takes steroids develops elevated eye pressure. The medical literature calls people who do “steroid responders,” and younger age consistently turns up as a risk factor. In one study of patients using steroid drops after cataract surgery, being under 50 was the only factor that remained significant after accounting for everything else.6PubMed. Incidence and risk factors for postoperative intraocular pressure response to topical prednisolone eye drops in patients undergoing phacoemulsification A study in children found that about 39% of pediatric patients on systemic steroids were classified as responders, with younger age, male sex, and higher steroid doses per body weight all independently associated with pressure elevation.7PubMed Central. Risk factors of pediatric steroid-induced ocular hypertension People with a family history of glaucoma, those with high myopia, and those with diabetes are also generally considered higher-risk, though these factors vary across studies.
The practical lesson is that if you fall into a higher-risk group, your doctor should be checking your eye pressure more frequently while you are on steroids. A dose threshold matters too: for systemic steroids, a pattern of elevated glaucoma risk has been observed at doses above about 7.5 mg per day of prednisone (or its equivalent).8PubMed. Dose-related patterns of glucocorticoid-induced side effects
Steroid Cataracts and How They Differ from Age-Related Ones
A steroid-induced cataract is not the same cloudiness that develops in most people’s lenses as they age. It has a distinctive form called a posterior subcapsular cataract, which grows at the very back of the lens. It is linked specifically to steroids that activate glucocorticoid receptors, and it involves lens cells migrating to abnormal locations and failing to differentiate properly.9PubMed. The etiology of steroid cataract Because of its central rear position, it tends to affect reading vision and vision in bright light disproportionately, since the opacity sits right in the path of focused light entering the pupil.
Recent research has added a new layer to the story. A 2025 study found that dexamethasone triggers a specific type of cell death called ferroptosis in lens cells, driven by a chain of molecular events involving the protein CD82 and the tumor suppressor P53. When researchers blocked ferroptosis with a drug called liproxstatin-1, the rate of steroid-induced cataracts dropped in animal models.10PubMed Central. Upregulation of ferroptosis in glucocorticoids-induced posterior subcapsular cataracts This is still early-stage science, but it opens a door to preventive treatments that might someday protect the lens while you are on necessary steroid therapy.
The dose threshold for cataract formation appears to be low. One analysis of glucocorticoid side-effect patterns found that cataracts showed an elevated frequency even below 5 mg per day of prednisone, a lower threshold than for most other steroid side effects.8PubMed. Dose-related patterns of glucocorticoid-induced side effects That is a dose many people with autoimmune conditions take for months or years.
Central Serous Chorioretinopathy
This condition, often shortened to CSC or CSCR, is one of the more paradoxical steroid-related eye problems. Fluid leaks under the retina, typically at the center of your visual field, causing blurred or distorted vision and sometimes dark spots. What makes it unusual is that corticosteroids are normally the go-to treatment for inflammation, yet CSC is one condition that steroids actually trigger or worsen rather than fix. It has been described as the only “inflammatory” choroiditis not linked to infection that is precipitated by glucocorticoids.11Eye. Central serous chorioretinopathy: an update on pathogenesis and treatment
CSC is commonly associated with glucocorticoid therapy in its various forms.12PubMed Central. Central serous chorioretinopathy as a cause of vision loss in chronic relapsing inflammatory optic neuropathy In one published case, a 24-year-old man developed black spots in his vision just three days after starting oral prednisolone for facial nerve palsy. After the steroid was tapered off, his vision improved within a week.13PubMed Central. Steroid-induced central serous retinopathy The key clinical message is that if you develop central visual disturbances while on steroids, CSC should be on the radar. Unlike glaucoma or cataracts, CSC often resolves once the steroid is discontinued, but recurrent or chronic cases can leave lasting retinal damage.
Steroid Eye Drops, Inhalers, and Other Routes
People often assume that if a steroid is applied locally, it only has local effects. That assumption is wrong. Even topical and ocular corticosteroids can produce systemic effects, including in rare cases hormonal disruption resembling Cushing syndrome.14Side Effects of Drugs Annual. Recent clinical studies on the side effects of medications that influence corticotrophins, corticosteroids, and prostaglandins When it comes to eye-specific harm, the route matters but none is exempt.
Inhaled corticosteroids, the daily maintenance therapy for millions of people with asthma and chronic lung disease, carry a measurable cataract risk at higher doses. A systematic review and meta-analysis found that daily inhaled corticosteroid doses of 1,000 micrograms or more are associated with a significant increase in cataract risk and a higher likelihood of eventually needing cataract surgery, though systemic steroids still carry a greater risk than inhalers.15PubMed Central. Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis If you use an inhaler, this is not a reason to stop it. Uncontrolled asthma is far more dangerous than a small increase in cataract risk. But it is a reason to mention your inhaler use at eye exams so your doctor can monitor for lens changes.
Intravitreal steroid injections, used to treat conditions like macular edema and uveitis, deliver the drug directly inside the eye. The most common adverse effects are raised intraocular pressure and cataract progression, along with rarer complications like infection or retinal detachment.16PubMed. Complications of intravitreal steroid injections A four-year study tracking repeated dexamethasone implant injections found that about 5% of patients developed elevated pressure after the first injection, with additional small percentages after subsequent rounds, and all were managed with eye drops alone.17PubMed Central. Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study
Infections and Wound Healing
Steroids suppress your immune system, and the eye is no exception. One concern is the reactivation of latent herpes virus in the eye. After eye surgery, the combination of surgical trauma and postoperative steroid drops can wake up herpes simplex or herpes zoster keratitis, causing painful corneal inflammation and potential scarring.18PubMed. Ocular surgery after herpes simplex and herpes zoster keratitis Delayed corneal wound healing is another recognized complication, which is why ophthalmologists carefully weigh steroid use after corneal procedures and sometimes use non-steroidal alternatives.
Children Face Higher Stakes
Children deserve separate attention because the consequences of unmonitored steroid use can be devastating in young eyes. Kids with allergic eye conditions like vernal keratoconjunctivitis sometimes end up on long-term steroid drops, and if no one checks their pressure, irreversible optic nerve damage can develop. A case series documented five children who arrived at a referral center already showing advanced glaucomatous damage and permanent visual loss from prolonged, unmonitored topical steroids.19PubMed Central. Case series of children with steroid-Induced glaucoma
Children with kidney disease treated with long courses of oral steroids also face risk. A study of 22 pediatric patients with nephrotic syndrome found that about 14% developed posterior subcapsular cataracts, with a significant link between longer treatment duration and cataract formation.20Philippine Journal of Ophthalmology. Steroid-induced cataract and glaucoma in pediatric patients with nephrotic syndrome Children cannot always articulate vision changes, which makes routine eye exams during steroid therapy even more important.
Can the Damage Be Reversed
This depends on which complication you are dealing with. Elevated eye pressure is often reversible. A prospective long-term study found that after steroids were stopped, about 65% of patients were off pressure-lowering treatment at six months, 97% at one year, and all of them by 18 months.21Eye. Prospective, long-term evaluation of steroid-induced glaucoma So if the pressure spike is caught early and the steroid is discontinued or switched, the outlook is good.
But if the elevated pressure has already damaged the optic nerve, that damage does not reverse. Glaucomatous nerve fiber loss is permanent, regardless of what caused the pressure increase. Cataracts, once formed, do not shrink or disappear when you stop steroids, though they can be surgically removed with excellent results. CSC, as noted earlier, often resolves on its own after steroid withdrawal, but chronic cases can cause lasting retinal changes.
When stopping the steroid is not an option and pressure remains elevated, laser treatment is one avenue. Selective laser trabeculoplasty has shown encouraging results specifically for steroid-induced glaucoma, with mean pressures dropping from roughly 28 mmHg to 17 mmHg within a few weeks in one study, and two-year failure rates lower than in other common forms of glaucoma.22PubMed. Selective laser trabeculoplasty in steroid-induced and uveitic glaucoma The same laser procedure has been described as safe and effective more broadly for steroid-induced pressure elevation.23PubMed. Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma
Why Steroids Are Still Used Despite These Risks
Given all of this, you might wonder why eye doctors continue to prescribe steroids at all. The answer is that no other class of drug controls inflammatory flare-ups as quickly and effectively. In uveitis, an inflammatory eye condition that can itself cause blindness, corticosteroids remain the frontline treatment because they stamp out inflammation fast, even though the same drugs carry a risk of cataracts and pressure elevation.24Springer Link / Drugs. Uveitis Therapy: The Corticosteroid Options The general approach is to use steroids at the lowest effective dose for the shortest possible time, then transition to steroid-sparing agents for long-term control.
After certain surgeries, nonsteroidal anti-inflammatory eye drops can substitute for steroids in some patients. A comparative study found that NSAIDs like nepafenac, bromfenac, and ketorolac were effective alternatives for controlling post-cataract inflammation and were actually better than steroids at controlling early postoperative pain and redness, though steroids still did the best job at suppressing internal inflammation.25PubMed Central. A comparative study of various topical nonsteroidal anti-inflammatory drugs to steroid drops for control of post cataract surgery inflammation These trade-offs are the kind of thing worth discussing with your surgeon if you know you are a steroid responder or have other risk factors.
The Monitoring Gap
Perhaps the most frustrating aspect of steroid-related eye damage is how preventable much of it is. The complications themselves are well understood, yet monitoring remains spotty. A population-based cohort study found that before starting glucocorticoids, fewer than 15% of patients received a referral for eye screening. Even among people who took steroids for more than a year, fewer than 25% were referred for eye disease screening at any point during their treatment.26PubMed Central. Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort study That gap means that many people develop avoidable complications simply because nobody measured their eye pressure or looked at their lenses.
If you are starting or already on long-term steroids, ask your prescribing doctor about a baseline eye exam and regular follow-ups. This is especially important for children, for people with a personal or family history of glaucoma, and for anyone on higher doses. The pressure rise is treatable and the cataracts are operable, but only if someone is looking for them.
What About Anabolic Steroids
Most of the research above involves corticosteroids, the anti-inflammatory drugs prescribed for everything from asthma to arthritis. But anabolic steroids, the muscle-building drugs used by some athletes and bodybuilders, carry their own distinct eye risks. Two cases of branch retinal vein occlusion, a blockage in one of the small veins draining the retina, were reported in young bodybuilders abusing anabolic steroids. The likely mechanism involved increased blood thickness and high blood pressure, both known consequences of anabolic steroid misuse. Both patients recovered their visual sharpness after stopping the drugs.27Acta Ophthalmologica. Branch retinal vein occlusion and anabolic steroids abuse in young bodybuilders
Retinal vein occlusion in a young, otherwise healthy person is unusual enough that it should raise questions about anabolic steroid use. The cardiovascular effects of these drugs, including elevated red blood cell counts, higher blood pressure, and changes in cholesterol, all create conditions favorable to clot formation in the delicate blood vessels of the eye. Unlike corticosteroid-related eye problems, the mechanism here is vascular rather than direct cellular toxicity in the eye’s drainage system or lens.
Adherence and Patient Awareness
A final complication worth mentioning is the human one. When patients are prescribed steroid eye drops or oral steroids with eye-monitoring instructions, compliance with those instructions is uneven. A study of patients with ocular inflammatory disease found that roughly half could not recall the purpose of their medications, even though about 79% reported that a healthcare provider had explained it to them.28Frontiers in Medicine. Medication adherence rates in patients with ocular inflammatory disease That disconnect matters because steroid eye drops often need to be tapered on a precise schedule, and skipping follow-up pressure checks is exactly how reversible pressure spikes become irreversible nerve damage. If you are prescribed a steroid in any form and told to schedule eye appointments, treat those appointments as part of the treatment itself rather than optional follow-up.